DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). The SCCT HPPC offers tools for administrators to navigate the complex landscape of insurance plans, billing and reimbursement on SCCT website, scct.org.

CMS 52

CMS Medicare Plaque Chest Pain 52

CardiacWire

JUNE 30, 2024

GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction. GLP-1s’ cardiovascular impact is likely to continue to expand, given growing evidence that it also improves HF symptoms.

Tricuspid 59

Tricuspid Reimbursement Medicare Electrophysiology 59